Maintaining the CRRT circuit: non-anticoagulant alternatives

Australian Critical Care

Volumn 19, Issue 4, 2006, Pages 133-138

  Davies, Hugh ^a   Leslie, Gavin ^b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b EDITH COWAN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ACUTE KIDNEY FAILURE; BLOOD CLOTTING; BLOOD FLOW VELOCITY; CLINICAL COMPETENCE; EQUIPMENT DESIGN; HEMOFILTRATION; HUMAN; INSTRUMENTATION; INTENSIVE CARE; METHODOLOGY; MONITORING; NURSE ATTITUDE; NURSING; PRACTICE GUIDELINE; REVIEW;

ANTICOAGULANTS; BLOOD COAGULATION; BLOOD FLOW VELOCITY; CLINICAL COMPETENCE; CRITICAL CARE; EQUIPMENT DESIGN; HEMOFILTRATION; HUMANS; KIDNEY FAILURE, ACUTE; MONITORING, PHYSIOLOGIC; NURSE'S ROLE; PRACTICE GUIDELINES;

EID: 34248677596     PISSN: 10367314     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1036-7314(06)80026-3     Document Type: Article

References (52)

1. Silvester W., Bellomo R., and Cole L. Epidemiology, management and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med 29 (2001) 1910-1915
2. Cutts M.W.J., Thomas A.N., and Kishen R. Transfusion requirements during continuous veno-venous haemofiltration: the importance of filter life. Intensive Care Med 26 (2000) 1694-1697
3. Baldwin I., Tan H.K., Bridge N., and Bellomo R. Possible strategies to prolong circuit life during hemofiltration: three controlled studies. Ren Fail 24 6 (2002) 839-848
4. Baldwin I., Bellomo R., and Koch B. Blood flow reductions during continuous renal replacement therapy and circuit life. Intensive Care Med 30 11 (2004) 2074-2079
5. Holt A.W., Bierer P., Bersten Ad., Bury L.K., and Vedig A.E. Continuous renal replacement therapy in critically ill patients: monitoring circuit function. Anaesthes Intensive Care 24 4 (1996) 423-429
6. Leslie G.D., and Thomas M.A.B. Filter life with veno venous (CVVHD) compared to arteriovenous (CAVHD) haemodiafiltration in intensive care acute renal failure (abstract). Anaesthes Intensive Care 19 3 (1991) 465-466
7. Leslie G.D., Jacobs I.G., and Clarke G.M. Proximally delivered dilute heparin does not improve circuit life in continuous veno-venous haemodiafiltmtion. Intensive Care Med 22 (1996) 1261-1264
8. Uchino S., Fealy N., Baldwin H., Morimatsu H., and Bellomo R. Continuous is not continuous: the incidence and impact of circuit down-time on ureamic control during continuous veno-venous haemofiltration. Intensive Care Med 29 (2003) 575-578
9. Bellomo R., Teede H., and Boyce N. Anticoagulant regimens in acute continuous hemodiafiltration. Intensive Care Med 19 (1993) 329-332
10. Martin P.Y., Chevrolet J.C., Suter P., and Favre H. Anticoagulation in patients treated by continuous venovenous hemofiltration: a retrospective study. Am J Kidney Dis 24 (1994) 806-812
11. Ronco C., Bellomo R., Homel P., Brendolan A., Maurizio D., Piccinni P., et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356 (2000) 26-30
12. Holt A.W., Bierer R., Glover R., Plummer J.L., and Bersten A.D. Conventional coagulation and thromboelastograph parameters and longevity of continuous renal replacement circuits. Intensive Care Med 28 (2002) 1649-1655
13. Stefanidis I., Hagel J., Frank D., and Maurin N. Hemostatic alterations during continuous venovenous hemofiltration in acute renal failure. Clin Nephrol 46 3 (1996) 199-205
14. Kox W.J., Rohr U., and Waurin H. Practical aspects of renal replacement therapy. Int J And Organs 19 (1996) 100-105
15. Tan H.K., Baldwin I., and Bellomo R. Continuous veno-venous haemofiltration without anticoagulation in high-risk patients. Intensive Care Med 26 (2000) 1652-1657
16. Schetz M. Anticoagulation for continuous renal replacement therapy. Curr Opin Anaesthesiol 14 (2001) 143-149
17. Lane D.A., and Bowry S.K. The scientific basis for selection of measures of thrombogenicity. Nephrol Dial Transplant 9 Suppl 2 (1993) 8-28
18. Cardigan R., McGloin H., Mackie I., Machin S., and Singer M. Activation of the tissue factor pathway occurs during continuous venovenous hemofiltmtion. Kidney Int 55 (1999) 1568-1574
19. Hesselvik J.F., Malm J., Dahlback B., and Blomback M. Protein C, Protein S and C4b-Binding Protein in severe infection and septic shack. Thromb Haemost 65 2 (1991) 126-129
20. 5. Davenport A. The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit. Am J Kidney Dis 30 Suppl 4 (1997) S20-S27
21. Davenport A. Anticoagulation in patients with acute renal failure treated with continuous renal replacement therapies. Hemodial Int 2 (1998) 41-59
22. Macias W.L., Mueller B.A., Scarim S.K., Robinson M., and Rudy D.W. Continuous venovenous hemofiltration: an alternative to continuous arteriovenous hemofiltration and hemodiafiltration in acute renal failure. Am J Kidney Dis 18 4 (1991) 451-458
23. Storck M., Hartt H.W., Zimmerer E., and Inthom D. Comparison of pump, driven and spontaneous continuous haemofiltration in postoperative acute renal failure. Lancet 337 (1991) 452-455
24. Bellomo R. Choosing a therapeutic modality: hemofiltration versus hemodialysis versus hemodiafiltmtion. Semin Dial 9 2 (1996) 88-92
25. Wright S.E., Bodenham A., Short A.I.K., and Turney J.H. The provision and practice of renal replacement therapy on adult intensive care units in the United Kingdom. Anaesthesia 58 (2003) 1063-1069
26. Bellomo R., and Ronco C. Vascular access for continuous renal replacement therapy. In: Bellomo R., Baldwin I., Ronco C., and Golper T. (Eds). Atlas of Haemofiltration (2002), WB Saunders, Sydney 77-82
27. Canaud B., Leray-Moragues H., Leblanc M., Klouche K., Vela C., and Beraud J.J. Temporary vascular access for extracorporeal renal replacement therapies in acute renal failure patients. Kidney Int 53 Suppl.66 (1998) S142-S150
28. Oliver M.J. Acute dialysis catheters. Semin Dialy 14 6 (2001) 432-435
29. Atherikul K., Schwab S.J., and Conlon P.J. Adequacy of haemodialysis with cuffed central-vein catheters. Nephrol Dial Transplant 13 (1998) 745-749
30. Canaud B., Desmeules S., Klouche K., Leray-Moragues H., and Beraud J.J. Vascular access for dialysis in the intensive care unit. Best Pract Res Clin Anaesthesiol 18 1 (2004) 159-174
31. Baldwin I., Bridge N., and Elderkin T. Nursing issues, practices, and perspectives for the management of continuous renal replacement therapy in the intensive care unit. In: Ronco C., and Bellomo R. (Eds). Critical Care Nephrology. 1st ed (1998), Kluwer Academic Publishers, Dordrecht 1309-1325
32. Uldall R. Vascular access for continuous renal replacement therapy. Semin Dial 9 2 (1996) 93-97
33. Kaplow R., and Barry R. Continuous renal replacement therapies. Am J Nurs 102 11 (2002) 26-33
34. Bellomo R., and Ronco C. Circulation of the continuous artificial kidney: blood flow, pressures, clearances and the search for the best. Blood Purif 15 (1997) 354-365
35. http://www.lhsc.on.ca/critcare/icu/elearning/crn/crrt.html 10 May 2006
36. Jenkins R.D. The extra-corporeal circuit: physical principles and monitoring. In: Ronco C., and Bellomo R. (Eds). Critical Care Nephrology. 1st ed (1998), Kluwe Academic Publishers, Dordrecht
37. Jonee C.H. Continuous renal replacement therapy in acute renal failure: membranes for CRRT. Artif Organs 22 1 (1998) 2-7
38. Salmon J., Cardigan R., Mackie I., Cohen S.L., Machin S., and Singer M. Continuous venovenous haemofiltration using polyacrylonitrile filters does not activate contact system and intrinsic coagulation pathways. Intensive Care Med 23 (1997) 38-43
39. Gretz N., Quintet M., Ragaller M., Odenwalder W., Bender H.J., Rhomeiss P., et al. Low dose heparinization for anticoagulation in intensive care patients on continuous hemofiltmtion. Contrib Nephrol 116 (1995) 130-135
40. Dirkes S.M. Continuous renal replacement therapy: dialytic therapy for acute renal failure in intensive care. Nephrol Nurs J 27 6 (2000) 581-590
41. Clark W.R., Turk J.E., Kraus M.A., and Gao D. Dose determinants in continuous renal replacement therapy. Artif Organs 27 9 (2003) 815-820
42. Uchino S., Fealy N., Baldwin I., Morimatsu H., and Bellomo R. Pre-dilution versus post-dilution during continuous veno-venous hemofiltration: impact on filter and azotemic control. Nephron Clin Pract 94 (2003) c94-c98
43. Ward D.M., and Mehra R.L. Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int 43 Suppl 41 (1993) S237-S244
44. Palsson R., and Niles J.L. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 55 (1999) 1991-1997
45. Prasad G.V.R., Palevsky P.M., Burr R., Lesko J.M., Gupta B., and Greenberg A. Factors affecting system clotting in continuous renal replacement therapy: results of a randomised, controlled trial. Clin Nephrol 53 1 (2000) 55-60
46. Mitchell A., Daut A.E., Beiderlinden M., Schafers R.K., Heemann U., Kribben A., et al. A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD). Clin Nephrol 59 2 (2003) 106-114
47. Kursogiannis D.J., Mayers I., Chin W.D., and Gibney R.T. Regional citrate anticoagulation in continuous veno-venous hemodiafiltration. Am J Kidney Dis 35 5 (2000) 802-811
48. van de Wetering J., Westendrop R.G.J., van der Hoeven J.G., Stolk B., Feuth J.D.M., and Chang P.C. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient haemorrhage. J Am Soc Nephol 7 1 (1996) 145-150
49. Klingel R., Schaefer M., Schwarting A., Himmelsbach F., Altes U., Uhlenbusch-Korwer I., et al. Comparative analysis of procoagulatory activity of haemodialysis, haemofiltration and haemodiafiltration with a polysulfone membrane (APS) and with different modes of enoxaparin anticoagulation. Nephrol Dial Transplant 19 (2004) 164-170
50. Martin R.E., and Jurschak J. Nursing management of continuous renal replacement therapy. Semin Dial 9 2 (1996) 192-199
51. Baldwin I., and Elderkin T. Continuous hemofiltration: nursing perspectives in critical care. New Horiz 3 4 (1995) 738-747
52. 5. Baldwin I. Training, management and credentialing for CRRT in the ICU. Am J Kidney Dis 30 Suppl.4 (1997) S112-S116